S&P 500   3,821.55
DOW   30,946.99
QQQ   283.54
S&P 500   3,821.55
DOW   30,946.99
QQQ   283.54
S&P 500   3,821.55
DOW   30,946.99
QQQ   283.54
S&P 500   3,821.55
DOW   30,946.99
QQQ   283.54

Verici Dx Share Forecast, Price & News

GBX 22
-1.92 (-8.03%)
(As of 06/28/2022 09:00 PM ET)
Today's Range
50-Day Range
52-Week Range
387,718 shs
Average Volume
159,152 shs
Market Capitalization
£37.47 million
P/E Ratio
Dividend Yield
Price Target
30 days | 90 days | 365 days | Advanced Chart

Receive VRCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Verici Dx and its competitors with MarketBeat's FREE daily newsletter.

VRCI Stock Forecast (MarketRank)

Overall MarketRank

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

About Verici Dx

Verici Dx plc engages in developing and commercializing clinical diagnostics kidney transplant tests. The company was incorporated in 2020 and is based in Penarth, United Kingdom. As of July 10, 2020, Verici Dx plc is a former subsidiary of Renalytix AI plc.

VRCI Stock News Headlines

Verici Dx Share Chat
Verici Dx Plc (VRCI)
See More Headlines

Industry, Sector and Symbol

Diagnostics & Research
Year Founded


Pretax Margin


Sales & Book Value

Annual Sales
Cash Flow
GBX 6.68 per share
Book Value
GBX 8.50 per share


Free Float
Market Cap
£37.47 million
Not Optionable

Verici Dx Frequently Asked Questions

How has Verici Dx's stock performed in 2022?

Verici Dx's stock was trading at GBX 53 at the beginning of 2022. Since then, VRCI shares have decreased by 58.5% and is now trading at GBX 22.
View the best growth stocks for 2022 here

Who are Verici Dx's key executives?

Verici Dx's management team includes the following people:
  • Ms. Sara Barrington A.C.A., A.C.I.M., CEO & Exec. Director (Age 54, Pay $415.78k)
  • Mr. Salim Hamir F.C.A., Company Sec.

What is Verici Dx's stock symbol?

Verici Dx trades on the London Stock Exchange (LON) under the ticker symbol "VRCI."

How do I buy shares of Verici Dx?

Shares of VRCI and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Verici Dx's stock price today?

One share of VRCI stock can currently be purchased for approximately GBX 22.

How much money does Verici Dx make?

Verici Dx (LON:VRCI) has a market capitalization of £37.47 million.

How many employees does Verici Dx have?

Verici Dx employs 10 workers across the globe.

How can I contact Verici Dx?

The official website for Verici Dx is www.vericidx.com. The company can be reached via phone at 44 207 9338780.

This page (LON:VRCI) was last updated on 6/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.